Amgen Inc. operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Amgen Inc. with three other
companies in this sector in the United States:
sales of $5.29 billion
of which 78%
Gilead Sciences, Inc.
of which 22%
was Ranexa & Other), and
of which 81%
was Product revenues, net).
Amgen Inc. reported sales of $23.75 billion
December of 2018.
increase of 3.9%
versus 2017, when the company's sales were $22.85 billion.